128 related articles for article (PubMed ID: 27297086)
1. Study on the expression of PAK4 and P54 protein in breast cancer.
Bi Y; Tian M; Le J; Wang L; Liu X; Qu J; Hao M
World J Surg Oncol; 2016 Jun; 14(1):160. PubMed ID: 27297086
[TBL] [Abstract][Full Text] [Related]
2. [Expression of PAK4 in breast cancer and benign breast pathological changes].
Yang JX; Han YJ; Zheng H; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):981-3. PubMed ID: 20501374
[TBL] [Abstract][Full Text] [Related]
3. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
4. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
5. A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
Li Y; Zhang H; Zhao Y; Wang C; Cheng Z; Tang L; Gao Y; Liu F; Li J; Li Y; Li Y; Geng N; Rui X; Teng Y; Liu Y; Cao L; Kumar R; Jin F; Li F
Oncogene; 2019 Feb; 38(6):808-821. PubMed ID: 30177834
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
7. A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion.
Wang F; Gao Y; Tang L; Ning K; Geng N; Zhang H; Li Y; Li Y; Liu F; Li F
Biochem Biophys Res Commun; 2019 Apr; 511(2):404-408. PubMed ID: 30808546
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
9. P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion.
Li X; Li J; Li F
Oncol Rep; 2017 May; 37(5):2857-2864. PubMed ID: 28393218
[TBL] [Abstract][Full Text] [Related]
10. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion.
Lu W; Xia YH; Qu JJ; He YY; Li BL; Lu C; Luo X; Wan XP
Neoplasma; 2013; 60(5):493-503. PubMed ID: 23790167
[TBL] [Abstract][Full Text] [Related]
11. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
[TBL] [Abstract][Full Text] [Related]
12. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.
Li SQ; Wang ZH; Mi XG; Liu L; Tan Y
IUBMB Life; 2015 Oct; 67(10):768-77. PubMed ID: 26399456
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4.
Li Z; Li X; Xu L; Tao Y; Yang C; Chen X; Fang F; Wu Y; Ding X; Zhao H; Li M; Qian G; Xu Y; Ren J; Du W; Wang J; Lu J; Hu S; Pan J
Oncol Rep; 2017 Nov; 38(5):2705-2716. PubMed ID: 29048629
[TBL] [Abstract][Full Text] [Related]
14. PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis.
Guo Q; Su N; Zhang J; Li X; Miao Z; Wang G; Cheng M; Xu H; Cao L; Li F
Oncogene; 2014 Jun; 33(25):3277-87. PubMed ID: 23893240
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of 1-phenanthryl-tetrahydroisoquinoline derivatives as novel p21-activated kinase 4 (PAK4) inhibitors.
Song S; Li X; Guo J; Hao C; Feng Y; Guo B; Liu T; Zhang Q; Zhang Z; Li R; Wang J; Lin B; Li F; Zhao D; Cheng M
Org Biomol Chem; 2015 Mar; 13(12):3803-18. PubMed ID: 25705811
[TBL] [Abstract][Full Text] [Related]
16. PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destruction.
Tang L; Gao Y; Song Y; Li Y; Li Y; Zhang H; Li D; Li J; Liu C; Li F
Int J Biol Sci; 2020; 16(12):2235-2247. PubMed ID: 32549768
[TBL] [Abstract][Full Text] [Related]
17. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
[TBL] [Abstract][Full Text] [Related]
18. P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration.
Song B; Wang W; Zheng Y; Yang J; Xu Z
J Surg Res; 2015 Jun; 196(1):130-5. PubMed ID: 25791829
[TBL] [Abstract][Full Text] [Related]
19. Regulation of P21-activated kinase-4 by progesterone and tumor necrosis factor-α in human endometrium and its increased expression in advanced-stage endometriosis.
Kim SH; Kim SR; Ihm HJ; Oh YS; Chae HD; Kim CH; Kang BM
J Clin Endocrinol Metab; 2013 Feb; 98(2):E238-48. PubMed ID: 23293332
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells.
Yi KW; Kim SH; Ihm HJ; Oh YS; Chae HD; Kim CH; Kang BM
Fertil Steril; 2015 Apr; 103(4):1089-1097.e2. PubMed ID: 25637478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
